Literature DB >> 189577

Serum lipid and lipoprotein concentrations in chronic uremia.

H E Norbeck, L Orö, L A Carlson.   

Abstract

The concentrations of triglycerides and cholesterol have been determined in total serum and in the three major serum lipoprotein classes--very low (VLDL), low (LDL) and high (HDL) density lipoproteins-after an overnight fast in 39 patients with chronic uremia of more than 2 years' duration and with serum creatinine above 350 mumol/l. The values were compared with data from healthy male and female controls. The findings were similar for male and female uremics. Hypertriglyceridemia was common while serum cholesterol tended to be normal or subnormal. With the conventional typing system for hyperlipidemia, types II A, III and IV were present in 6,9 and 30%,respectively. The tryglyceride and cholesterol concentrations in VLDL were increased, while their normal relation for this lipoprotein class was maintained. In LDL the concentration of tryglycerides was increased, while that of cholesterol was low. The LDL composition, therefore, was changed to be more triglyceride-rich than normal. The changes in concentration and composition of LDL indicated that the levels of LDL 1 were raised and of LDL 2 decreased in chronic uremia. Increased levels of LDL tryglycerides occurred more frequently (40%) than increased levels of VLDL triglycerides (33%). The most striking and consistent lipoprotein abnormality was a low HDL cholesterol, which was not related to high VLDL levels. The HDL tryglycerides, on the other hand, tended to be somewhat high. The importance of the raised levels of the triglyceride-rich VLDL and LDL 1 and the decreased levels of HLD cholesterol for the rapid development of atherosclerotic vascular diseases which occur in chronic uremia is discussed. It is of interest in this context that both total cholesterol and LDL cholesterol were low. The possible mechanisms underlying the lipoprotein abnormalities in chronic uremia are discussed and it is suggested that they are complex.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 189577     DOI: 10.1111/j.0954-6820.1976.tb08270.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


  6 in total

1.  Humoral inhibitors of the immune response in uremia. II. Further characterization of an immunosuppressive factor in uremic serum.

Authors:  J Raskova; A B Morrison; S M Shea; K Raska
Journal:  Am J Pathol       Date:  1979-11       Impact factor: 4.307

2.  Severe type III hyperlipoproteinemia in two patients maintained on chronic hemodialysis.

Authors:  G Feussner; J Bommer; R Ziegler
Journal:  Klin Wochenschr       Date:  1990-01-19

Review 3.  Recent advances in the pathogenesis and nutritional treatment of chronic uremia.

Authors:  P Fürst; A Alvestrand; J Bergström
Journal:  Z Ernahrungswiss       Date:  1982-09

4.  The evidence for the antiatherogenicity of high density lipoprotein in man.

Authors:  N E Miller
Journal:  Lipids       Date:  1978-12       Impact factor: 1.880

Review 5.  [Alterations of fat metabolism in renal disease - pathogenetic mechanisms (author's transl)].

Authors:  W H Hörl; M Hörl; A Heidland
Journal:  Klin Wochenschr       Date:  1982-04-01

6.  Abnormalities in hepatic lipase in chronic renal failure: role of excess parathyroid hormone.

Authors:  M Klin; M Smogorzewski; Z Ni; G Zhang; S G Massry
Journal:  J Clin Invest       Date:  1996-05-15       Impact factor: 14.808

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.